# N-acetylcysteine Effects on Tetrahydrocannabinol

> **NCT02335060** · EARLY_PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 5 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Delta-9-THC
- **DRUG:** N-acetylcysteine
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02335060
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05-02
- **Primary completion:** 2014-09-16
- **Final completion:** 2014-09-16
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Feasibility pilot was completed
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335060, "N-acetylcysteine Effects on Tetrahydrocannabinol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02335060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*